Targeting primary human leukaemia cells with RNA interference: Bcr-Abl targeting inhibits myeloid progenitor self-renewal in chronic myeloid leukaemia cells
- PMID: 15842662
- DOI: 10.1111/j.1365-2141.2005.05468.x
Targeting primary human leukaemia cells with RNA interference: Bcr-Abl targeting inhibits myeloid progenitor self-renewal in chronic myeloid leukaemia cells
Abstract
We have investigated functional outcome of challenging primary chronic myeloid leukaemia (CML) cells with Bcr-Abl fusion sequence-directed RNA interference (RNAi). We targeted the Bcr-Abl b3a2 variant, by RNAi, in primary chronic phase CML cells, and detected strikingly reduced proliferation of myeloid precursor cells expressing this variant. Lack of an effect in cells expressing a distinct Bcr-Abl variant confirmed the specificity of the response. Through the functional targeting of an oncogene in primary human tumour cells, we have demonstrated that Bcr-Abl enhances CML progenitor cell amplification, and that RNAi may be suitable for development as a specific anti-leukaemia treatment.
Similar articles
-
Gene therapy for BCR-ABL+ human CML with dual phosphorylation resistant p27Kip1 and stable RNA interference using an EBV vector.J Gene Med. 2006 Oct;8(10):1251-61. doi: 10.1002/jgm.959. J Gene Med. 2006. PMID: 16952195
-
RNA interference targeting of Bcr-Abl increases chronic myeloid leukemia cell killing by 17-allylamino-17-demethoxygeldanamycin.Leuk Res. 2006 May;30(5):553-60. doi: 10.1016/j.leukres.2005.09.013. Epub 2005 Nov 2. Leuk Res. 2006. PMID: 16260034
-
Chronic myeloid leukaemia: stem cell derived but progenitor cell driven.Clin Sci (Lond). 2005 Jul;109(1):13-25. doi: 10.1042/CS20040336. Clin Sci (Lond). 2005. PMID: 15966868 Review.
-
[Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells].Zhonghua Yi Xue Za Zhi. 2005 Jan 19;85(3):198-202. Zhonghua Yi Xue Za Zhi. 2005. PMID: 15854468 Chinese.
-
Molecular evolution of chronic myeloid leukaemia.Semin Cancer Biol. 2001 Aug;11(4):313-23. doi: 10.1006/scbi.2001.0387. Semin Cancer Biol. 2001. PMID: 11513567 Review.
Cited by
-
HDAC6-an Emerging Target Against Chronic Myeloid Leukemia?Cancers (Basel). 2020 Jan 29;12(2):318. doi: 10.3390/cancers12020318. Cancers (Basel). 2020. PMID: 32013157 Free PMC article. Review.
-
Protease-activated receptor-4 and purinergic receptor P2Y12 dimerize, co-internalize, and activate Akt signaling via endosomal recruitment of β-arrestin.J Biol Chem. 2017 Aug 18;292(33):13867-13878. doi: 10.1074/jbc.M117.782359. Epub 2017 Jun 26. J Biol Chem. 2017. PMID: 28652403 Free PMC article.
-
Protease-activated Receptor-4 Signaling and Trafficking Is Regulated by the Clathrin Adaptor Protein Complex-2 Independent of β-Arrestins.J Biol Chem. 2016 Aug 26;291(35):18453-64. doi: 10.1074/jbc.M116.729285. Epub 2016 Jul 11. J Biol Chem. 2016. PMID: 27402844 Free PMC article.
-
Exercise-induced norepinephrine decreases circulating hematopoietic stem and progenitor cell colony-forming capacity.PLoS One. 2014 Sep 2;9(9):e106120. doi: 10.1371/journal.pone.0106120. eCollection 2014. PLoS One. 2014. PMID: 25180783 Free PMC article. Clinical Trial.
-
Proliferation inhibition and apoptosis induction of imatinib-resistant chronic myeloid leukemia cells via PPP2R5C down-regulation.J Hematol Oncol. 2013 Sep 3;6:64. doi: 10.1186/1756-8722-6-64. J Hematol Oncol. 2013. PMID: 24004697 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous